Insider Transactions in Q4 2025 at Phathom Pharmaceuticals, Inc. (PHAT)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 19
2025
|
Asit Parikh |
BUY
Exercise of conversion of derivative security
|
Direct |
8,750
+6.68%
|
$87,500
$10.3 P/Share
|
|
Dec 18
2025
|
Robert Charles Breedlove Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
230
-0.48%
|
$3,680
$16.28 P/Share
|
|
Dec 17
2025
|
Steven L Basta President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
31,502
-21.68%
|
$472,530
$15.36 P/Share
|
|
Dec 17
2025
|
Steven L Basta President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
62,038
+29.92%
|
-
|
|
Dec 17
2025
|
Anne Marie Cook Chief Legal Off. & Corp. Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
7,703
-44.35%
|
$115,545
$15.36 P/Share
|
|
Dec 17
2025
|
Anne Marie Cook Chief Legal Off. & Corp. Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
17,370
+50.0%
|
-
|
|
Nov 28
2025
|
Steven L Basta President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
48,375
-36.75%
|
$725,625
$15.62 P/Share
|
|
Nov 28
2025
|
Steven L Basta President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
90,000
+40.61%
|
-
|
|
Nov 03
2025
|
Robert Charles Breedlove Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
524
-1.09%
|
$6,812
$13.51 P/Share
|